BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18374133)

  • 1. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells.
    Tu CF; Tai HC; Chen CM; Huang TT; Lee JM; Yang TS; Chen CH; Tseng YL; Chou NK; Lee PH
    Transplant Proc; 2008 Mar; 40(2):578-80. PubMed ID: 18374133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival of HLA-DR15+ pig skin in SCID mice after reconstitution with human peripheral blood mononuclear cells and under short-term immunosuppression.
    Tai HC; Tu CF; Lee JM; Ho LL; Tseng YL; Chou NK; Yang TS; Weng CN; Lee PH; Chang KJ; Tang YB
    Transplant Proc; 2008 Mar; 40(2):570-3. PubMed ID: 18374131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin graft of double transgenic pigs of N-acetylglucosaminyltransferase III (GnT-III) and DAF (CD55) genes survived in cynomolgus monkey for 31 days.
    Fujita T; Miyagawa S; Ezoe K; Saito T; Sato N; Takahagi Y; Murakami H; Matsunami K; Shirakura R; Taniguchi N
    Transpl Immunol; 2004 Dec; 13(4):259-64. PubMed ID: 15589738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells.
    Kuddus RH; Metes DM; Nalesnik MA; Logar AJ; Rao AS; Fung JJ
    Transpl Immunol; 2004; 13(1):15-24. PubMed ID: 15203124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
    Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
    Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of human HLA transgenes in pigs by fluorescence in situ hybridization (FISH) for adjuvant study of human xenotransplantation.
    Wang BT; Tu CF; Hsieh LJ; Tai HC; Chiu YL; Lee JM; Kuo SJ; Tsuji K; Lee CJ
    Xenotransplantation; 2004 Sep; 11(5):471-5. PubMed ID: 15303984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculin-induced delayed-type hypersensitivity reaction in a model of hu-PBMC-SCID mice grafted with autologous skin.
    Tsicopoulos A; Pestel J; Fahy O; Vorng H; Vandenbusche F; Porte H; Eraldi L; Wurtz A; Akoum H; Hamid Q; Wallaert B; Tonnel AB
    Am J Pathol; 1998 Jun; 152(6):1681-8. PubMed ID: 9626072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.
    Coates PT; Krishnan R; Kireta S; Johnston J; Russ GR
    Gene Ther; 2001 Aug; 8(16):1224-33. PubMed ID: 11509955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
    Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
    Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged skin allograft survival in Scid mice reconstituted with isogeneic bone marrow stem cell antigen-1-positive cells and thymus tissue.
    Gao Z; Tibbles L; Yilmaz S; Gao Y; MacDonald A
    Transplant Proc; 2005 Jun; 37(5):2300-2. PubMed ID: 15964404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of HLA-DP transgenic pigs for the study of xenotransplantation.
    Tu CF; Tsuji K; Lee KH; Chu R; Sun TJ; Lee YC; Weng CN; Lee CJ
    Int Surg; 1999; 84(2):176-82. PubMed ID: 10408293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
    Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.